Depo-Provera (medroxyprogesterone acetate) NDC 0009-0746

NDC codes

FDA NDC Directory

Product NDC (as listed)0009-0746Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00009-0746Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0009-0746-30	00009074630	1 VIAL in 1 CARTON (0009-0746-30) / 1 mL in 1 VIALMarketed from Oct 29, 1992
0009-0746-35	00009074635	25 VIAL in 1 PACKAGE (0009-0746-35) / 1 mL in 1 VIALMarketed from Oct 29, 1992

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Depo-Provera
Generic name (nonproprietary): medroxyprogesterone acetate
Active ingredients: Medroxyprogesterone acetate — 150 mg/mL
Dosage form: Injection, Suspension
Route: Intramuscular
Labeler: Pharmacia & Upjohn Company LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020246
Marketing start: Oct 29, 1992
Listing expires: Dec 31, 2027
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 0009-0746_92e204f9-b8ac-4187-bb16-49af41de61a2SPL ID 92e204f9-b8ac-4187-bb16-49af41de61a2SPL set ID 199cf13e-0859-4a73-9b45-e700d0cd1049RxCUI 1000126, 1000128, 1000153, 1000154UNII C2QI4IOI2G
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J1050 — Injection, medroxyprogesterone acetate, 1 mg

Billing unit: 1 mg. Units on the claim = dose given ÷ 1 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400009074630 followed by a unit qualifier and the quantity

Package 00009-0746-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 25, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Depo-Provera CI is indicated for use by females of reproductive potential to prevent pregnancy. Depo-Provera CI is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of Depo-Provera CI is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. (1, 5.1) Limitations of Use : The use of Depo-Provera CI is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ].

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020246

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020246
Product	Strength	Form · route	Labeler	Product NDC
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	A-S Medication Solutions	50090-5925
Depo-Proveramedroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Pharmacia & Upjohn Company LLC	0009-7376
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	A-S Medication Solutions	50090-5619
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Prasco Laboratories	66993-370
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Prasco Laboratories	66993-371